PACILIO, MASSIMILIANO
PACILIO, MASSIMILIANO
DIPARTIMENTO DI SCIENZE RADIOLOGICHE, ONCOLOGICHE E ANATOMO-PATOLOGICHE
123I-mibg Imaging For Parkinson’S Disease: The Diagnostic Value Of The Early Heart-to-mediastinum Count Ratio
2018 Frantellizzi, V.; Pacilio, M.; Farcomeni, A.; Borrazzo, C.; DE VINCENTIS, Giuseppe
A 3-variable prognostic score (3-PS) for overall survival prediction in metastatic castration-resistant prostate cancer treated with223Radium-dichloride
2018 Frantellizzi, Viviana; Farcomeni, Alessio; Follacchio, Giulia Anna; Pacilio, Massimiliano; Pellegrini, Rosanna; Pani, Roberto; de Vincentis, Giuseppe
Analysis of Clinical parameters for the outcame prediction of mCRPC patients treated with Ra-223-dichloride
2017 Frantellizzi, V; Follacchio, Ga; Sollaku, S; Lazri, J; Farcomeni, A; Pacilio, M; Liberatore, M; Monteleone, F; De Vincentis, G
Correlation between Bone Lesion Dosimetry and Pain Outcome in Patients (pts) with Castration-Resistant Prostate Cancer (CRPC)undergoing 223Ra-dichloride Therapy
2016 Follacchio, Ga; Frantellizzi, V; Pacilio, M; Cassano, B; Pani, R; Pellegrini, R; De Vincentis, G
Deep seated tumour treatments with electrons of high energy delivered at FLASH rates: the example of prostate cancer
2021 Sarti, Alessio; De Maria, Patrizia; Battistoni, Giuseppe; De Simoni, Micol; Di Felice, Cinzia; Dong, Yunsheng; Fischetti, Marta; Franciosini, Gaia; Marafini, Michela; Marampon, Francesco; Mattei, Ilaria; Mirabelli, Riccardo; Muraro, Silvia; Pacilio, Massimiliano; Palumbo, Luigi; Rocca, Loredana; Rubeca, Damiana; Schiavi, Angelo; Sciubba, Adalberto; Tombolini, Vincenzo; Toppi, Marco; Traini, Giacomo; Trigilio, Antonio; Patera, Vincenzo
Definition of a Predictive Score to guide therapeutic management in metastatic CRPC patients eligible to Radium-223
2017 Follacchio, Ga; Frantellizzi, V; Pontico, M; DE FEO, MARIA SILVIA; Monteleone, F; Liberatore, M; Farcomeni, A.; Pacilio, M; De Vincentis, G
Diagnostic value of the early heart-to-mediastinum count ratio in cardiac 123I-mIBG imaging for Parkinson's disease
2021 Frantellizzi, Viviana; Lavelli, Valentina; Ferrari, Cristina; Sardaro, Angela; Farcomeni, Alessio; Pacilio, Massimiliano; Borrazzo, Cristian; Pani, Roberto; Rubini, Giuseppe; Vincentis, Giuseppe De
Dose-response correlation in radioiodine therapy of hyperthyroidism from nodular thyroid disease
2017 Pacilio, M; Ventroni, G; Frantellizzi, V; Cassano, B; Verdolino, E; Montesano, T; De Vincentis, G; Mango, L
Dosimetric principles of targeted radiotherapy and radioimmunotherapy
2021 De Vincentis, G.; Frantellizzi, V.; Pacilio, M.
Experimental validation of an innovative approach in biokinetics study for personalised dosimetry of molecular radiation therapy treatments
2023 Mancini-Terracciano, C; Ambrosino, A; Campana, L; Cassano, B; Collamati, F; Faccini, R; Iaccarino, G; Mirabelli, R; Morganti, S; Nicolanti, F; Pacilio, M; Soriani, A; Solfaroli Camillocci, E
Feasibility of 223 Ra imaging for clinical purpose
2015 De Vincentis, G; Follacchio, Ga; Frantellizzi, V; Pellegrini, R; Di Castro, E; Pani, R; Garkavaya, T; Caruso, M; Iacobelli, S; Monteleone, F; Liberatore, M; Cassano, B; Lorenzon, L; Mango, L; Ventroni, G; Pacilio, M
Feasibility of 223Ra quantitative imaging for lesion dosimetry
2015 Follacchio, Ga; Frantellizzi, V; Pellegrini, R; Pani, R; Pacilio, M; Cassano, B; Liberatore, M; Monteleone, F; Garkavaya, T; Ventroni, Guido; Mango, L; De Vincentis, G
I-131 differentiated thyroid cancer therapy in pediatric patients based on I-123 pre-therapeutic red marrow dosimetry
2016 Pacilio, M; Orlandi, C; Cannata, V; Donatiello, S; Garganese, Mc; Genovese, E; Lorenzon, L; Pizzoferro, M; Villani, Mf; Longo, M
Immunoscintigraphy for therapy decision making and follow-up of biological therapies
2016 Lauri, Chiara; Auletta, S.; Carideo, Luciano; Valabrega, Stefano; Pacilio, Massimiliano; Signore, Alberto; Galli, Filippo
Lesion dosimetry and follow-up for a large group of castration-resistant prostate cancer (CRPC) patients and bone metastases treated with 223Ra therapy
2018 Pacilio, M.; Frantellizzi, V.; Verdolino, E.; Borrazzo, C.; Cassano, B.; Ventroni, G.; Mango, L.; De Vincentis, G.
Lesion dosimetry for Ra-223 therapy of bone metastases from castration-resistant prostate cancer: patients eligibility criterion and update of dosimetric assessments
2016 Pacilio, M; Cassano, B; De Vincentis, G; Ventroni, G; Frantellizzi, V; Follacchio, Ga; Pellegrini, R; Di Castro, E; Ialongo, P; Mango, L; Pani, R
Lesions dosimetry for 223Ra therapy of bone metastases from castration-resistant prostate cancer
2016 Pacilio, M.; Cassano, B.; Ventroni, G.; De Vincentis, G.; Pellegrini, R.; Di Castro, E.; Frantellizzi, V.; Follacchio, G. A.; Lorenzon, L.; Ialongo, P.; Mango, L.; Pani, R.
Myocardial blood flow estimates from dynamic contrast-enhanced magnetic resonance imaging: three quantitative methods
2018 Borrazzo, Cristian; Galea, Nicola; Pacilio, Massimiliano; Altabella, Luisa; Preziosi, Enrico; Carni, Marco; Ciolina, Federica; Vullo, Francesco; Francone, Marco; Catalano, Carlo; Carbone, Iacopo
Personalized dosimetry in the context of radioiodine therapy for differentiated thyroid cancer
2022 Pacilio, Massimiliano; Conte, Miriam; Frantellizzi, Viviana; De Feo, Maria Silvia; Pisani, Antonio Rosario; Marongiu, Andrea; Nuvoli, Susanna; Rubini, Giuseppe; Spanu, Angela; De Vincentis, Giuseppe
Psychological status and pain outcome evaluation in patients with painful bone metastases from castration resistant prostate cancer treated with 223Radium.
2016 Frantellizzi, V; Longo, F; Schinzari, G; Liberatore, M; Pacilio, M; Bianco, V; Follacchio, Ga; De Vincentis, G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 123I-mibg Imaging For Parkinson’S Disease: The Diagnostic Value Of The Early Heart-to-mediastinum Count Ratio | 2018 | Frantellizzi, V.; Pacilio, M.; Farcomeni, A.; Borrazzo, C.; DE VINCENTIS, Giuseppe | |
| A 3-variable prognostic score (3-PS) for overall survival prediction in metastatic castration-resistant prostate cancer treated with223Radium-dichloride | 2018 | Frantellizzi, Viviana; Farcomeni, Alessio; Follacchio, Giulia Anna; Pacilio, Massimiliano; Pellegrini, Rosanna; Pani, Roberto; de Vincentis, Giuseppe | |
| Analysis of Clinical parameters for the outcame prediction of mCRPC patients treated with Ra-223-dichloride | 2017 | Frantellizzi, V; Follacchio, Ga; Sollaku, S; Lazri, J; Farcomeni, A; Pacilio, M; Liberatore, M; Monteleone, F; De Vincentis, G | |
| Correlation between Bone Lesion Dosimetry and Pain Outcome in Patients (pts) with Castration-Resistant Prostate Cancer (CRPC)undergoing 223Ra-dichloride Therapy | 2016 | Follacchio, Ga; Frantellizzi, V; Pacilio, M; Cassano, B; Pani, R; Pellegrini, R; De Vincentis, G | |
| Deep seated tumour treatments with electrons of high energy delivered at FLASH rates: the example of prostate cancer | 2021 | Sarti, Alessio; De Maria, Patrizia; Battistoni, Giuseppe; De Simoni, Micol; Di Felice, Cinzia; Dong, Yunsheng; Fischetti, Marta; Franciosini, Gaia; Marafini, Michela; Marampon, Francesco; Mattei, Ilaria; Mirabelli, Riccardo; Muraro, Silvia; Pacilio, Massimiliano; Palumbo, Luigi; Rocca, Loredana; Rubeca, Damiana; Schiavi, Angelo; Sciubba, Adalberto; Tombolini, Vincenzo; Toppi, Marco; Traini, Giacomo; Trigilio, Antonio; Patera, Vincenzo | |
| Definition of a Predictive Score to guide therapeutic management in metastatic CRPC patients eligible to Radium-223 | 2017 | Follacchio, Ga; Frantellizzi, V; Pontico, M; DE FEO, MARIA SILVIA; Monteleone, F; Liberatore, M; Farcomeni, A.; Pacilio, M; De Vincentis, G | |
| Diagnostic value of the early heart-to-mediastinum count ratio in cardiac 123I-mIBG imaging for Parkinson's disease | 2021 | Frantellizzi, Viviana; Lavelli, Valentina; Ferrari, Cristina; Sardaro, Angela; Farcomeni, Alessio; Pacilio, Massimiliano; Borrazzo, Cristian; Pani, Roberto; Rubini, Giuseppe; Vincentis, Giuseppe De | |
| Dose-response correlation in radioiodine therapy of hyperthyroidism from nodular thyroid disease | 2017 | Pacilio, M; Ventroni, G; Frantellizzi, V; Cassano, B; Verdolino, E; Montesano, T; De Vincentis, G; Mango, L | |
| Dosimetric principles of targeted radiotherapy and radioimmunotherapy | 2021 | De Vincentis, G.; Frantellizzi, V.; Pacilio, M. | |
| Experimental validation of an innovative approach in biokinetics study for personalised dosimetry of molecular radiation therapy treatments | 2023 | Mancini-Terracciano, C; Ambrosino, A; Campana, L; Cassano, B; Collamati, F; Faccini, R; Iaccarino, G; Mirabelli, R; Morganti, S; Nicolanti, F; Pacilio, M; Soriani, A; Solfaroli Camillocci, E | |
| Feasibility of 223 Ra imaging for clinical purpose | 2015 | De Vincentis, G; Follacchio, Ga; Frantellizzi, V; Pellegrini, R; Di Castro, E; Pani, R; Garkavaya, T; Caruso, M; Iacobelli, S; Monteleone, F; Liberatore, M; Cassano, B; Lorenzon, L; Mango, L; Ventroni, G; Pacilio, M | |
| Feasibility of 223Ra quantitative imaging for lesion dosimetry | 2015 | Follacchio, Ga; Frantellizzi, V; Pellegrini, R; Pani, R; Pacilio, M; Cassano, B; Liberatore, M; Monteleone, F; Garkavaya, T; Ventroni, Guido; Mango, L; De Vincentis, G | |
| I-131 differentiated thyroid cancer therapy in pediatric patients based on I-123 pre-therapeutic red marrow dosimetry | 2016 | Pacilio, M; Orlandi, C; Cannata, V; Donatiello, S; Garganese, Mc; Genovese, E; Lorenzon, L; Pizzoferro, M; Villani, Mf; Longo, M | |
| Immunoscintigraphy for therapy decision making and follow-up of biological therapies | 2016 | Lauri, Chiara; Auletta, S.; Carideo, Luciano; Valabrega, Stefano; Pacilio, Massimiliano; Signore, Alberto; Galli, Filippo | |
| Lesion dosimetry and follow-up for a large group of castration-resistant prostate cancer (CRPC) patients and bone metastases treated with 223Ra therapy | 2018 | Pacilio, M.; Frantellizzi, V.; Verdolino, E.; Borrazzo, C.; Cassano, B.; Ventroni, G.; Mango, L.; De Vincentis, G. | |
| Lesion dosimetry for Ra-223 therapy of bone metastases from castration-resistant prostate cancer: patients eligibility criterion and update of dosimetric assessments | 2016 | Pacilio, M; Cassano, B; De Vincentis, G; Ventroni, G; Frantellizzi, V; Follacchio, Ga; Pellegrini, R; Di Castro, E; Ialongo, P; Mango, L; Pani, R | |
| Lesions dosimetry for 223Ra therapy of bone metastases from castration-resistant prostate cancer | 2016 | Pacilio, M.; Cassano, B.; Ventroni, G.; De Vincentis, G.; Pellegrini, R.; Di Castro, E.; Frantellizzi, V.; Follacchio, G. A.; Lorenzon, L.; Ialongo, P.; Mango, L.; Pani, R. | |
| Myocardial blood flow estimates from dynamic contrast-enhanced magnetic resonance imaging: three quantitative methods | 2018 | Borrazzo, Cristian; Galea, Nicola; Pacilio, Massimiliano; Altabella, Luisa; Preziosi, Enrico; Carni, Marco; Ciolina, Federica; Vullo, Francesco; Francone, Marco; Catalano, Carlo; Carbone, Iacopo | |
| Personalized dosimetry in the context of radioiodine therapy for differentiated thyroid cancer | 2022 | Pacilio, Massimiliano; Conte, Miriam; Frantellizzi, Viviana; De Feo, Maria Silvia; Pisani, Antonio Rosario; Marongiu, Andrea; Nuvoli, Susanna; Rubini, Giuseppe; Spanu, Angela; De Vincentis, Giuseppe | |
| Psychological status and pain outcome evaluation in patients with painful bone metastases from castration resistant prostate cancer treated with 223Radium. | 2016 | Frantellizzi, V; Longo, F; Schinzari, G; Liberatore, M; Pacilio, M; Bianco, V; Follacchio, Ga; De Vincentis, G |